title: Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.
abstract: Arsenic exposure has been linked to an increased incidence of atherosclerosis. Previously, we have shown in vitro and in vivo that arsenic inhibits transcriptional activation of the liver X receptors (LXRs), key regulators of lipid homeostasis. Therefore, we evaluated the role of LXRα in arsenic-induced atherosclerosis using the apoE(-/-) mouse model. Indeed, deletion of LXRα protected apoE(-/-) mice against the proatherogenic effects of arsenic. We have previously shown that arsenic changes the plaque composition in apoE(-/-) mice. Arsenic decreased collagen content in the apoE(-/-) model, and we have observed the same diminution in LXRα(-/-)apoE(-/-) mice. However, the collagen-producing smooth muscle cells (SMCs) were decreased in apoE(-/-), but increased in LXRα(-/-)apoE(-/-). Although transcriptional activation of collagen remained the same in SMC from both genotypes, arsenic-exposed LXRα(-/-)apoE(-/-) plaques had increased matrix metalloproteinase activity compared with both control LXRα(-/-)apoE(-/-) and apoE(-/-), which could be responsible for both the decrease in plaque collagen and the SMC invasion. In addition, arsenic increased plaque lipid accumulation in both genotypes. However, macrophages, the cells known to retain lipid within the plaque, were unchanged in arsenic-exposed apoE(-/-) mice, but decreased in LXRα(-/-)apoE(-/-). We confirmed in vitro that these cells retained more lipid following arsenic exposure and are more sensitive to apoptosis than apoE(-/-). Mice lacking LXRα are resistant to arsenic-enhanced atherosclerosis, but arsenic-exposed LXRα(-/-)apoE(-/-) mice still present a different plaque composition pattern than the arsenic-exposed apoE(-/-) mice.
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
authors.forename: Maryse
authors.initials: M
authors.lastname: Lemaire
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Lemarié
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
authors.forename: Manuel
authors.initials: M
authors.lastname: Flores Molina
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Guilbert
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Lehoux
authors.affiliation: *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 koren.mann@mcgill.ca.
authors.forename: Koren K
authors.initials: KK
authors.lastname: Mann
mesh_terms: D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics; D017209:Apoptosis / Q000235:genetics; D018053:Arsenites / Q000633:toxicity*; D050197:Atherosclerosis / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology / Q000517:prevention & control; D049109:Cell Proliferation / Q000235:genetics; D004195:Disease Models, Animal; D004785:Environmental Pollutants / Q000633:toxicity*; D017353:Gene Deletion; D050356:Lipid Metabolism / Q000235:genetics; D008055:Lipids / Q000097:blood; D000071518:Liver X Receptors; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D018345:Mice, Knockout; D057093:Orphan Nuclear Receptors / Q000235:genetics*; D058226:Plaque, Atherosclerotic / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology / Q000517:prevention & control; D017670:Sodium Compounds / Q000633:toxicity*
chemical_list: D001057:Apolipoproteins E; D018053:Arsenites; D004785:Environmental Pollutants; D008055:Lipids; D000071518:Liver X Receptors; C000605214:Nr1h3 protein, mouse; D057093:Orphan Nuclear Receptors; D017670:Sodium Compounds; C017947:sodium arsenite
keywords: LXRα; MMP-9; arsenic; atherosclerosis; macrophages; smooth muscle cells